Breaking the Invisible Barriers: Unleashing the Full Potential of Immune Checkpoint Inhibitors in Oncogene-Driven Lung Adenocarcinoma

por Kwok, Hoi-Hin, Yang, Jiashuang, Lam, David Chi-Leung
Publicado 2023

Single‐cell transcriptomic analysis uncovers intratumoral heterogeneity and drug‐tolerant persister in ALK‐rearranged lung adenocarcinoma

por Kwok, Hoi‐Hin, Li, Huiyu, Yang, Jiashuang, Deng, Junyang, Lee, Nerissa Chui‐Mei, Au, Timmy Wing‐Kuk, Sit, Alva Ko‐Yung, Hsin, Michael Kuan‐Yew, Ma, Stephanie Kwai‐Yee, Cheung, Lydia Wai‐Ting, Girard, Luc, Fujimoto, Junya, Wistuba, Ignacio Ivan, Gao, Boning, Minna, John Dorrance, Lam, David Chi‐Leung
Publicado 2023

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

por Xu, Yan, Xiang, Zheng, Alnaggar, Mohammed, Kouakanou, Léonce, Li, Jiawei, He, Junyi, Yang, Jiashuang, Hu, Yi, Chen, Yan, Lin, Li, Hao, Jianlei, Li, Jingxia, Chen, Jibing, Li, Man, Wu, Qingling, Peters, Christian, Zhou, Qinghua, Li, Jianshuang, Liang, Yingqing, Wang, Xiaohua, Han, Baohui, Ma, Meili, Kabelitz, Dieter, Xu, Kecheng, Tu, Wenwei, Wu, Yangzhe, Yin, Zhinan
Publicado 2020